bromodeoxyuridine has been researched along with misonidazole in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gutin, PH; Nelson, DF; Saunders, WM; Sheline, GE; Urtasun, RC | 1 |
| Silver, AR; Stratford, IJ; Walling, JM | 1 |
| Glatstein, E; Kinsella, TJ | 1 |
| Nakajima, T; Onoyama, Y; Tanaka, M | 1 |
| Geard, CR; Rutledge-Freeman, MH; Spunberg, JJ | 1 |
| Ando, K; Hirayama, R; Kashino, G; Kinashi, Y; Koike, S; Liu, Y; Masunaga, S; Ono, K; Suzuki, M; Takata, T; Tanaka, H; Uzawa, A | 1 |
| Civelek, AC; Huang, T; Jiang, H; Li, J; Li, XF; Ng, CK; Postel, GC; Shen, B | 1 |
1 review(s) available for bromodeoxyuridine and misonidazole
| Article | Year |
|---|---|
Recent and current investigations of radiation therapy of malignant gliomas.
Topics: Brachytherapy; Brain; Brain Neoplasms; Bromodeoxyuridine; Carmustine; Glioma; Helium; Humans; Hyperbaric Oxygenation; Hyperthermia, Induced; Mesons; Metronidazole; Middle Aged; Misonidazole; Neon; Neutrons; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy, High-Energy | 1986 |
6 other study(ies) available for bromodeoxyuridine and misonidazole
| Article | Year |
|---|---|
The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
Topics: Animals; Benzamides; Bromodeoxyuridine; Cell Survival; Cells, Cultured; Cricetinae; DNA; Dose-Response Relationship, Drug; Glutathione; Misonidazole; NAD; Oxygen; Radiation-Sensitizing Agents | 1986 |
Clinical experience with intravenous radiosensitizers in unresectable sarcomas.
Topics: Adolescent; Adult; Aged; Bone and Bones; Bone Neoplasms; Bromodeoxyuridine; Female; Humans; Injections, Intravenous; Male; Middle Aged; Misonidazole; Radiation Dosage; Radiation-Sensitizing Agents; Sarcoma | 1987 |
[Radiation sensitizers: with special reference to hypoxic cell sensitizers].
Topics: Animals; Bromodeoxyuridine; Cells, Cultured; Humans; Misonidazole; Neoplasms; Oxygen; Partial Pressure; Radiation-Sensitizing Agents | 1986 |
A comparison of the cytological effects of three hypoxic cell radiosensitizers.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Etanidazole; Lung; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Sister Chromatid Exchange | 1982 |
Influence of manipulating hypoxia in solid tumors on the radiation dose-rate effect in vivo, with reference to that in the quiescent cell population.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Carbon Radioisotopes; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Radiation; Female; Fluorescent Antibody Technique; Gamma Rays; Mice; Mice, Inbred C3H; Misonidazole; Niacinamide; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Vitamin B Complex | 2010 |
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment | 2012 |